Sta znaci na Engleskom DVOSTRUKO SLIJEPOM - prevod na Енглеском

• double-blind
• the double blind
• double blind
• double-masked

Примери коришћења Dvostruko slijepom на Хрватском и њихови преводи на Енглески

U dvostruko slijepom ispitivanju(SP512 I dio) 177 bolesnika primalo je rotigotin, a 96 bolesnika primalo je placebo.
In the double blind study SP512 Part I, 177 patients received rotigotine and 96 patients received placebo.

Ameluz je također uspoređen s placebo liječenjem u randomiziranom, dvostruko slijepom kliničkom ispitivanju s uključenih 122 bolesnika.
Ameluz was also compared with placebo treatment in a randomised, double-blind clinical trial enrolling 122 patients.

Ona dijagnosticira novi soj gripe, Tada nalazi učinkovite antivirusno Na obližnjem laboratoriju u sredini od dvostruko slijepom pokusu.
She diagnosed the new flu strain, then located an effective antiviral at a nearby lab in the midst of a double-blind trial.

Ova biljka je testiran u dvostruko slijepom studije koje dokazuju učinkovitost biljke u proizvodnji energije i bolje zdravlje među CFS bolesnika.
This herb has been tested in double blind studies that prove the effectiveness of the herb in producing energy and better health among CFS patients.

Nuspojave navedene u tablici u nastavku prijavljene su u barem jednog od 321 bolesnika koji su primili delamanid u gore navedenom dvostruko slijepom, placebom kontroliranom kliničkom ispitivanju.
The adverse reactions listed in the table below were reported in at least one of the 321 patients receiving delamanid in the double blind placebo controlled clinical trial mentioned above.

U ovom krutom kontroliranom, dvostruko slijepom, placebo ispitivanju, sudionici su koristili izgubljene više funti u usporedbi s onima koji su koristili placebo.
In this rigidly controlled, double blind, placebo trial, the participants that availed of the lost several more pounds compared to those that used placebo.

Djelotvornost i sigurnost Cimzije se ocjenjivala u odraslih bolesnika s aktivnim RA koji prethodno nisu bili liječeni DMARD-ovima u randomiziranom, placebom kontroliranom, dvostruko slijepom kliničkom ispitivanju C-EARLY.
The efficacy and safety of Cimzia was assessed in DMARD-naïve adult patients with active RA in a randomized, placebo-controlled, double-blind clinical trial C-EARLY.

Djelotvornost cjepiva Cervarix procijenjena je u dvostruko slijepom, randomiziranom kliničkom ispitivanju faze III(HPV-015) koje je uključilo ukupno 5777 žena u dobi od 26 godina i više.
The efficacy of Cervarix was assessed in a double-blind, randomised Phase III clinical trial(HPV-015) that included a total of 5777 women aged 26 years and older.

Djelotvornost i sigurnost empagliflozina kao dodatka bazalnom inzulinu sa ili bez metformina i/ili sulfonilureje ocijenjena je u dvostruko slijepom, placebom kontroliranom ispitivanju u trajanju od 78 tjedna.
The efficacy and safety of empagliflozin as add-on to basal insulin with or without metformin and/or a sulphonylurea was evaluated in a double-blind, placebo-controlled trial of 78 weeks duration.

Učinak palonosetrona na QTc interval procijenjen je u dvostruko slijepom, randomiziranom, usporednom placebom i pozitivno(moksifloksacin) kontroliranom ispitivanju u odraslih muškaraca i žena.
The effect of palonosetron on QTc interval was evaluated in a double blind, randomised, parallel, placebo and positive(moxifloxacin) controlled trial in adult men and women.

Smatramo da bi svatko mogao imati koristi ukoliko su najradikalniji protagonisti dokazne medicine organizirali i sudjelovali u dvostruko slijepom, randomiziranom, placebo kontroliranom, preklopnom sudaru padobrana.
We think that everyone might benefit if the most radical protagonists of evidence based medicine organised and participated in a double blind, randomised, placebo controlled, crossover trial of the parachute.

GoYin dvostruko slijepom kliničkom ispitivanju, studija, stres, depresija, bijes, umor i negativne emocije poput zbunjenosti GoYin ljudi, uz smanjenje rasta u energetici, izvještaj je rekao.
GoYin double-blind clinical study, study, kev nyuaj siab, depression, anger, fatigue and negative emotions such as confusion GoYin people, while reducing growth in energy, the report said.

Djelotvornost i sigurnost monoterapije empagliflozinom ocijenjena je u dvostruko slijepom, placebom i aktivno kontroliranom ispitivanju u trajanju od 24 tjedna u prethodno neliječenih bolesnika.
The efficacy and safety of empagliflozin as monotherapy was evaluated in a double-blind, placebo- and active-controlled study of 24 weeks duration in treatment-naïve patients.

U dvostruko slijepom ispitivanju kontroliranom podlogom, primijenjeno je do dva ciklusa liječenja lijekom Picato 150 µg/g u 450 bolesnika sa 4-8 aktiničkih keratoza u liječenom području od 25 cm2 na licu i vlasištu.
In a double blind, vehicle-controlled study, up to two treatment courses of Picato 150 mcg/g were administered to 450 patients with 4-8 AKs in a 25 cm2 treatment area on the face or scalp.

Djelotvornost protiv invazivne bolesti procijenjena je u velikom randomiziranom, dvostruko slijepom kliničkom ispitivanju u multietničkoj populaciji u Sjevernoj Kaliforniji ispitivanje Kaiser Permanente.
Efficacy against invasive disease was assessed in a large-scale randomised, double-blind, clinical trial in a multiethnic population in Northern California Kaiser Permanente trial.

U jednom, dvostruko slijepom, placebom kontroliranom ispitivanju, 161 bolesnik s MDR-TB-om primio je 8 tjedno liječenje s 100 mg delamanida dvaput dnevno u kombinaciji s individualiziranim OBR-om koji preporučuje SZO.
In a single, double blind, placebo controlled study, 161 MDR-TB patients received 8 weeks treatment with delamanid 100 mg twice daily in combination with WHO recommended individualised OBR.

Djelotvornost vortioksetina 10 ili 20 mg dnevno je nadalje bila pokazana u 12 tjedenskom, dvostruko slijepom usporednom ispitivanju fleksibilnih doza naspram agomelatina 25 ili 50 mg dnevno u bolesnika s MDD.
The efficacy of vortioxetine 10 or 20 mg/day was further demonstrated in a 12-week, double-blind, flexible-dose comparative study versus agomelatine 25 or 50 mg/day in patients with MDD.

U jednom randomiziranom, dvostruko slijepom, placebom kontroliranom kliničkom ispitivanju u odraslih, uspoređivala se kombinacija abakavira, lamivudina i zidovudina s kombinacijom indinavira, lamivudina i zidovudina.
One randomised, double blind, placebo controlled clinical study in adults has compared the combination of abacavir, lamivudine and zidovudine to the combination of indinavir, lamivudine and zidovudine.

Djelotvornost ustekinumaba ispitivana je u 110 pedijatrijskih bolesnika s umjerenom do teškom plak psorijazom u dobi od 12 do 17 godina u multicentričnom, randomiziranom, dvostruko slijepom, placebo kontroliranom ispitivanju faze III CADMUS.
The efficacy of ustekinumab was studied in 110 paediatric patients aged 12 to 17 years with moderate to severe plaque psoriasis in a multicenter, Phase 3, randomised, double blind, placebo controlled study CADMUS.

U dvostruko slijepom, placebom kontroliranom, randomiziranom kliničkom ispitivanju u odraslih bolesnika s psorijatičnim artritisom, 184 bolesnika je također primilo polivalentno pneumokokno polisaharidno cjepivo u 4. tjednu.
In a double blind, placebo controlled, randomised clinical study in adult patients with psoriatic arthritis 184 patients also received a multivalent pneumococcal polysaccharide vaccine at week 4.

Sigurnost i djelotvornost lijeka Eylea bile su procijenjene u randomiziranom, multicentričnom, dvostruko slijepom ispitivanju kontroliranom placebo postupkom u liječenju bolesnika azijatskog podrijetla s miopijskim CNV-om koji prethodno nisu bili liječeni.
The safety and efficacy of Eylea were assessed in a randomised, multi-centre, double-masked, sham- controlled study in treatment-naïve, Asian patients with myopic CNV.

U dvostruko slijepom dijelu tri placebom kontrolirana klinička ispitivanja faze III u bolesnika s Dupuytrenovom kontrakturom, 17% bolesnika liječenih Xiapexom imalo je blage reakcije(tj. svrbež) nakon najviše 3 injekcije.
In the double blind portion of the three phase 3 placebo-controlled clinical studies in Dupuytren's contracture, 17% of Xiapex-treated patients had mild reactions(i.e. pruritus) after up to 3 injections.

Sigurnost i djelotvornost lenalidomida procijenjena je u multicentričnom, randomiziranom, dvostruko slijepom ispitivanju faze III(MM-015) na 3 skupine bolesnika u dobi od 65 godina ili starijih, koji su imali kreatinin u serumu< 2, 5 mg/dL.
The safety and efficacy of lenalidomide was assessed in a Phase III multicenter, randomized double blind 3 arm study(MM-015) of patients who were 65 years or older and had a serum creatinine< 2.5 mg/dL.

U produžetku ispitivanja otvorenog tipa, stopa promjene u NIS-LL tijekom 12 mjeseci terapije bila je slična onoj opaženoj u bolesnika koji su bili randomizirani i liječeni tafamidisom u prethodnom dvostruko slijepom 18-mjesečnom razdoblju.
In the open-label extension study, the rate of change in the NIS-LL during the 12 months of treatment was similar to that observed in those patients randomised and treated with tafamidis in the previous double blind 18 month period.

Ezofagealna kandidijaza: U randomiziranom, dvostruko slijepom ispitivanju mikafungina u usporedbi s flukonazolom, u prvoj liniji liječenja kandidijaze jednjaka, 518 bolesnika primilo je najmanje jednu dozu ispitivanog lijeka.
Oesophageal Candidiasis: In a randomised, double-blind study of micafungin versus fluconazole in the first-line treatment of oesophageal candidiasis, 518 patients received at least a single dose of study drug.

Osoba koja na terapiju reagira pozitivno je definirana kao bolesnik koji dosljedno hoda većom brzinom tijekom najmanje tri od mogućih četiri posjeta u dvostruko slijepom razdoblju u odnosu na maksimalnu brzinu u pet posjeta koji nisu bili slijepi niti u okviru terapije.
A responder was defined as a patient who consistently had a faster walking speed for at least three visits out of a possible four during the double blind period as compared to the maximum value among five non-double blind off-treatment visits.

U kontroliranom, dvostruko slijepom kliničkom ispitivanju u trajanju od 2 godine početno liječenje pramipeksolom je značajno odgodilo pojavu motoričkih komplikacija te smanjilo njihovu pojavnost u usporedbi s početnim liječenjem primjenom levodope.
In a controlled double blind clinical trial of 2 year duration, initial treatment with pramipexole significantly delayed the onset of motor complications, and reduced their occurrence compared to initial treatment with levodopa.

Učinak simeprevira od 150 mg jedanput na dan i 350 mg jedanput na dan tijekom 7 dana na QT interval bilo je procijenjeno u randomiziranom, dvostruko slijepom, s placebom i pozitivnom kontrolom kontroliranom(moksifloksacin 400 mg jedanput na dan),4- smjernom ukriženom ispitivanju u 60 zdravih ispitanika.
The effect of simeprevir 150 mg once daily and 350 mg once daily for 7 days on the QT interval was evaluated in a randomised, double-blind, placebo- and positive-controlled(moxifloxacin 400 mg once daily), 4-way cross-over study in 60 healthy subjects.

Radi se o randomiziranom, dvostruko slijepom ispitivanju faze III kojim se uspoređivala djelotvornost i sigurnost primjene lijeka Avastin u kombinaciji s interferonom(IFN) alfa-2a u odnosu na liječenje samim interferonom alfa-2a u prvoj liniji liječenja metastatskog karcinoma bubrežnih stanica.
This was a phase III randomised double-blind trial conducted to evaluate the efficacy and safety of Avastin in combination with interferon(IFN) alfa-2a versus IFN alfa-2a alone as first-line treatment in mRCC.

Sigurnost i djelotvornost lijeka Eylea procijenjene su u randomiziranom, multicentričnom, dvostruko slijepom ispitivanju s aktivnom kontrolom u bolesnika s makularnim edemom kao posljedicom BRVO-a(VIBRANT), što je uključivalo hemi-retinalnu vensku okluziju.
The safety and efficacy of Eylea were assessed in a randomised, multi-centre, double-masked, active- controlled study in patients with macular oedema secondary to BRVO(VIBRANT) which included Hemi-Retinal Vein Occlusion.